These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6120793)

  • 1. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of double-blindness at the conclusion of the beta-Blocker Heart Attack Trial.
    Byington RP; Curb JD; Mattson ME
    JAMA; 1985 Mar 22-29; 253(12):1733-6. PubMed ID: 3974051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in the beta blocker heart attack trial: circumstances surrounding death.
    Peters RW; Byington R; Arensberg D; Friedman LM; Romhilt DW; Barker A; Laubach C; Wilner GW; Goldstein S
    J Chronic Dis; 1987; 40(1):75-82. PubMed ID: 3543049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Beta-Blocker Heart Attack Trial in perspective.
    Goldstein S
    Cardiology; 1983; 70(5):255-62. PubMed ID: 6141847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Beta Blocker Heart Attack Trial: recruitment experience.
    Goldstein S; Byington R
    Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How informed is informed consent? The BHAT experience.
    Howard JM; DeMets D
    Control Clin Trials; 1981 Dec; 2(4):287-303. PubMed ID: 6120794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Blocker Heart Attack Trial: impact of propranolol therapy on ventricular arrhythmias.
    Morganroth J; Lichstein E; Byington R
    Prev Med; 1985 May; 14(3):346-57. PubMed ID: 3903736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
    Lichstein E; Morganroth J; Harrist R; Hubble E
    Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic beta blockade therapy in patients after myocardial infarction.
    Pratt CM; Roberts R
    Am J Cardiol; 1983 Oct; 52(7):661-4. PubMed ID: 6137945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.